Value of Analysing Under-utilised Leftover Tissue (VauLT)

Launched by ROYAL MARSDEN NHS FOUNDATION TRUST · Feb 5, 2019

Keywords

ClinConnect Summary

The VauLT trial is studying how to make better use of leftover tissue from cancer surgeries. Researchers believe that analyzing these leftover samples, which often go to waste, can provide a more complete picture of a tumor. This is important because tumors can vary a lot within themselves, and understanding this variation might help in developing better treatments for patients. By blending the leftover tumor tissue, the study aims to create samples that can better represent the entire tumor, which could improve diagnosis and treatment strategies.

To participate in the trial, you need to be over 18 years old and have leftover tissue from a cancer surgery that is at least 1 gram of tumor and 1 gram of normal tissue. You must also have given consent for your tissue to be used for research. If you're interested, the trial is currently recruiting participants, and you can expect to contribute to important research that could help improve cancer treatment for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Leftover formalin-fixed tissue (ie that would be otherwise discarded by histopathology) from cancer surgery.
• • 2. Tissues for Research consent has been provided.
• • 3. Patient age \>18yo.
• • 4. Minimum of 1 gram of residual tumour remaining in leftover surgical tissue
• • 5. Minimum of 1 gram of normal tissue present.
• Exclusion Criteria:
• • 1. Advanced Practitioner in histological dissection deems tumour sample to be inadequate.
• • 2. Leftover surgical tumour tissue greater than 20kg.